Skip to main content

Peer Review reports

From: A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma

Original Submission
23 Oct 2022 Submitted Original manuscript
12 Jan 2023 Reviewed Reviewer Report
19 Mar 2023 Reviewed Reviewer Report
31 Mar 2023 Author responded Author comments - Sameer Rastogi
Resubmission - Version 2
31 Mar 2023 Submitted Manuscript version 2
18 Apr 2023 Author responded Author comments - Sameer Rastogi
Resubmission - Version 3
18 Apr 2023 Submitted Manuscript version 3
21 Apr 2023 Author responded Author comments - Sameer Rastogi
Resubmission - Version 4
21 Apr 2023 Submitted Manuscript version 4
15 May 2023 Reviewed Reviewer Report
17 Jun 2023 Author responded Author comments - Sameer Rastogi
Resubmission - Version 5
17 Jun 2023 Submitted Manuscript version 5
19 Jun 2023 Author responded Author comments - Sameer Rastogi
Resubmission - Version 6
19 Jun 2023 Submitted Manuscript version 6
Publishing
21 Jun 2023 Editorially accepted
8 Jul 2023 Article published 10.1186/s12885-023-11099-4

You can find further information about peer review here.

Back to article page